A full study is in progress, but who pays after the pilot?

Drug treatment for melanoma: progress, but who pays? Comment.

doi: 10.5694/mja12.10955 elanoma is 10 times more common in Australia than in most countries,1 and kills more than 1300 Australians every year.2 The good news is that we now have effective drug treatments for metastatic melanoma. Two drugs, ipilimumab3,4 and vemurafenib,5 are now approved by the United States Food and Drug Administration and the Australian Therapeutic Goods Administration in re...

Who Is a Bilingual?

The question of who is and who is not a bilingual is more difficult to answer than it first appears. Bilingualism was long regarded as the equal mastery of two languages, a definition that still prevails in certain glossaries of linguistics. However, today's complex world requires a more exact definition and analysis of the competencies that community members require to interact with speakers o...

Who Pays for Disinflation?

Many economic observers applaud the current rate of inflation in the United States, claiming that the rate is so low that inflation has ceased to matter much in the decisions of individuals and businesses. Some, such as Martin Feldstein (1997), want to see inflation fall still further--to zero--arguing that such a reduction would yield substantial gains by allowing resources to be allocated mor...

Migrants' healthcare: who pays?

Who pays for obesity?

Adult obesity is a growing problem. From 1962 to 2006, obesity prevalence nearly tripled to 35.1 percent of adults. The rising prevalence of obesity is not limited to a particular socioeconomic group and is not unique to the United States. Should this widespread obesity epidemic be a cause for alarm? From a personal health perspective, the answer is an emphatic "yes." But when it comes to justi...